Currently out of the existing stock ratings of Balaji Prasad, 20 are a SELL (11.24%), 19 are a HOLD (10.67%), 139 are a BUY (78.09%).

Balaji Prasad

Work Performance Price Targets & Ratings Chart

Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 45.74% that have a potential upside of 21.31% achieved within 205 days.

Balaji Prasad’s has documented 354 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, . Common Stock at 13-Aug-2024.

Wall Street Analyst Balaji Prasad

Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 4/2/2020. The price target of $3 was fulfilled within 7 days with a profit of $1.2 (66.67%) receiving and performance score of 95.24.

Average potential price target upside

of $72.87 (13.64%) on IDXX (IDEXX LABORATORIES).
of $33.18 (24.59%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $25.97 (39.76%) on LGND (LIGAND PHARMACEUTICALS ORPORATED).

BHC Bausch Health Companies CHRS Coherus BioSciences ELAN Elanco Animal Health ENDP Endo International PLC EOLS Evolus IDXX IDEXX Laboratories JAZZ Jazz Pharmaceuticals PLC LGND Ligand Pharmaceuticals orporated PAHC Phibro Animal Health PCRX Pacira Pharmaceuticals RDY Dr. Reddy’s Laboratories Ltd ADR RVNC Revance The TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis VTRS Viatris AMAG AMAG Pharmaceuticals AMRX Amneal Pharmaceuticals, . Common Stock CVET Covetrus MNK Mallinckrodt plc PYPD PolyPid RVLP RVL Pharmaceuticals PLC ALVO Alvotech TARS Tarsus Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Douglas Miehm (RBC)